1Y Annualised Return
▼-4.53%
3Y Annualised Return
▲15.37%
5Y Annualised Return
▲35.23%
Godavari Drugs SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹65,00,000
Would have become ₹63,54,407 (-2.24%)
Daily SIP of ₹25,000 would have become ₹63,54,407 in 1 year with a gain of ₹-1,45,592 (-2.24%)
Godavari Drugs Stock Performance
Today’s Low - High
93.00
95.80
93.00
95.80
52 Week Low - High
79.00
155.00
79.00
155.00
Open
93.00
Prev. Close
94.65
Volume
2,041.00
Total Traded Value
1.94 L
Godavari Drugs Fundamental
Market Cap (in crs)
71.50
Face Value
10
Turnover (in lacs)
1.94
Key Metrics
Qtr Change %
38.74% Fall from 52W High
1
Dividend yield 1yr %
0
Godavari Drugs Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
95.69
Current Price
5Day EMA
95.70
10Day EMA
96.50
12Day EMA
96.60
20Day EMA
96.60
26Day EMA
96.40
50Day EMA
96.00
100Day EMA
98.10
200Day EMA
101.60
5Day SMA
95.80
10Day SMA
96.50
20Day SMA
97.80
30Day SMA
95.90
50Day SMA
94.90
100Day SMA
95.80
150Day SMA
102.60
200Day SMA
109.30
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 1617 Rs | 2041 Rs |
Week Rs | 3051 Rs | 3656 Rs |
Month Rs | 5471 Rs | 7825 Rs |
Resistance & Support
94.58
Pivot
Resistance
First Resistance
96.17
Second Resistance
97.38
Third Resistance
98.97
Support
First Support
93.37
Second support
91.78
Third Support
90.57
Relative Strength Index
47.09
Money Flow Index
41.11
MACD
0.25
MACD Signal
0.87
Average True Range
4.29
Average Directional Index
37.24
Rate of Change (21)
1.02
Rate of Change (125)
-22.68
Similar stocks
Similar Stocks
Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | 81.58 | 40.4 | 91.87 | 51.90 | -5.98% | 15.03% | -21.39% | -19.67% | -7.58% | 0.00% | 146.29 | 42.57 | 4.31 | |
- | 85.04 | 60.55 | 104 | 80.00 | 8.79% | 16.84% | -6.20% | 5.85% | -6.87% | 0.00% | 414.65 | 47.87 | 1.51 | |
- | 66.79 | 185.05 | 398 | 210.55 | 5.44% | -10.00% | -30.21% | -3.89% | 84.42% | 0.00% | 15.73 | 42.57 | 1.88 | |
Vista Pharmaceuticals Ltd. | - | 11.44 | - | - | - | - | - | - | - | - | - | - | - | - |
- | 62.93 | 12.52 | 33.49 | 13.18 | -10.73% | -31.14% | -53.64% | -46.28% | -67.46% | 0.00% | 69.72 | 42.57 | 0.75 | |
- | 81.97 | 2.82 | 6.25 | 3.65 | -0.57% | 2.35% | -32.16% | -9.84% | 266.32% | 0.00% | 174.00 | 42.57 | 2.62 |
Godavari Drugs Company background
Founded in: 1987
Managing director: Mukund Kakani
Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates, through its manufacturing facility at Nanded, Maharashtra, India.. Sulphamethoxazole (SMX), the main product of the company, is a widely used antibacterial drug enjoying good export demand. The Company incorporated in December, 1987, has multiple production blocks for APIs, drug intermediates and fine chemicals. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.: 450 tpa) and diethyl oxalate, DEO (cap.: 750 tpa), and diversifying into the manufacture of trimetroprim, TMP (cap.: 144 tpa).The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections. The backward integration into SMO and DEO will enhance valueaddition. In fact, Siris and Chemox Chemicals, both having good capacities of SMX, have recently gone in for the production of SMO. In 2000 the company introduced Pyrazyamide in the market. Since the product is being well accepted in the market the company is planning to increase the capacity of Pyrazyamide of 180 TPA and have also finalised on other products Cislactum,which is a intermediate used to produce Diltiazem an anti anginal drug.The Company combine their intrinsic strengths in chemistry with capabilities of process development, right from laboratory scale topilot scale in pilot plant and finally manufacturing at the commercial scale in manufacturing facilities, which are in line with cGMP requirements. A combination of chemistry knowledge, with engineering strengths, along with good analytical backup enables Godavari Drugs to develop, scale, up and manufacture products right from laboratory to commercial scale.
As of 13 Jun, 2025, GODAVARI share price is ₹95. The stock opened at ₹93 and had closed at ₹94.6 the previous day. During today’s trading session, GODAVARI share price moved between ₹93.00 and ₹95.80, with an average price for the day of ₹94.00. Over the last 52 weeks, the stock has recorded a low of ₹79.00 and a high of ₹155.00. In terms of performance, GODAVARI share price has declined by 22.1% over the past six months and has declined by 4.53% over the last year.
Godavari Drugs FAQs
How to buy Godavari Drugs shares?
You can easily buy Godavari Drugs shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Godavari Drugs stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account